AARD vs CPB · $284.4M cap vs P/E 12, rev $10.25B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Campbell’s Co (CPB) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
AARD currently screens at market cap $284.4M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Not investment advice. Open the AARD and CPB stock pages for the full models.
Not investment advice.